Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Diabetes Mellitus, Type 2, Date of authorisation: 03/04/2020, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Wet Macular Degeneration;Macular Edema;Diabetes Complications;Myopia, Degenerative, Date of authorisation: 22/01/2007, Revision: 43, Status: Authorised
Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Anovulation;Reproductive Techniques, Assisted;Infertility, Female;Hypogonadism, Date of authorisation: 20/10/1995, Revision: 26, Status: Authorised
Modelling and simulation: questions and answers
Timetable: Annual renewal application of conditional marketing authorisation
Timetable: Type II variation and worksharing application weekly assessment
Patients' and Consumers' Working Party
Healthcare Professionals' Working Party
Union Product Database: release notes
Release notes - production release version 1.6.34 September 2023 - Veterinary Medicinal Products Regulation: Union Product Database